Xenpozyme

Xenpozyme is a rare-disease pharmaceutical, the first of it’s kind.

It was developed to treat Acid Sphingomyelinase Deficiency (ASMD), more commonly known as Niemman-Pick Disease.

For the launch, a full HCP campaign consisting of digital and print pieces such as core visual aids, emails, banners and guides were developed.

With a keen eye for aesthetics and strong understanding of user engagement, I created these series of projects to deliver and captivate a strategic message. From responsive design to personalized content, I’m dedicated to optimizing the communication and experience for brands and their audiences.

Pharmaceutical

Creative Direction and Design | 2021